NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients

On Monday, NovoCure Ltd NVCR and Zai Lab Limited ZLAB revealed topline data from the Phase 3 PANOVA-3 trial of Tumor-Treating Fields (TTFields) therapy concomitantly with gemcitabine and nab-paclitaxel as a first-line treatment for unresectable, locally advanced pancreatic adenocarcinoma.The pivotal trial met its primary endpoint, demonstrating a statistically significant improvement in median overall survival (mOS) versus control.Also Read: FDA Approves NovoCure’s Portable Device Producing Tumor-Treating E ...